Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
47 participants
INTERVENTIONAL
2023-03-01
2024-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise, Problem-Solving and Education
Individualized exercise program Weekly Goals setting and problem-solving session to create a weekly action plan Four Assigned interactive educational modules
Exercise, Problem-Solving Session and Education
Complete assigned exercises three times a week Complete Action plan co-developed Complete part or all of one of the four interactive educational modules
Usual Care
Participants will complete their daily routines as they typically do.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise, Problem-Solving Session and Education
Complete assigned exercises three times a week Complete Action plan co-developed Complete part or all of one of the four interactive educational modules
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* received chemotherapy and/or radiation therapy
* have access to mobile device or computer
* have basic computer or mobile device skills,
* have a significant level of fatigue defined as \>3 on 0-10 scale using the Oneitem Fatigue Scale
Exclusion Criteria
* do not have a signed medical release by their physician or physician extender indicating that the participant can safely participate in the exercise program,
* chronic fatigue prior to cancer diagnosis, such as fibromyalgia
* are unable to follow verbal or written assessment instructions, are non-English speaking
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Dayton
OTHER
University of Cincinnati
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anne Fleischer
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne Fleischer, Ph.D
Role: PRINCIPAL_INVESTIGATOR
University of Cincinnati
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Cincinnati
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HRP - 503
Identifier Type: -
Identifier Source: org_study_id